Your session is about to expire
← Back to Search
Colchicine 0.5 mg die for Heart Failure (COLpEF Trial)
COLpEF Trial Summary
This trial will help determine if colchicine is an effective treatment for HFpEF by reducing inflammation.
- Heart Failure
- Inflammation
- Colchicine
COLpEF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.COLpEF Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is Colchicine 0.5 mg bid effective in treating?
"Typically, colchicine is given at a dosage of 0.5mg twice a day to patients suffering from gout flares. However, it can also be used to ameliorate the symptoms of Behcet's syndrome, postcommissurotomy syndrome, and familial mediterranean fever."
Is Colchicine 0.5 mg bid considered to be a safe medication?
"Colchicine 0.5 mg bid is currently in Phase 2 of clinical trials. While there is some evidence supporting its safety, more research is needed to confirm its efficacy."
Would someone who is over the age of 70 still be able to participate in this research project?
"This particular medical trial is only enrolling patients that are between 40 to 80 years old. In contrast, there are 54 clinical trials for patients under 18 and 1026 for those over 65."
Is Colchicine 0.5 mg bid a new medication being trialed?
"As of now, there are a total of 32 clinical trials ongoing for Colchicine 0.5 mg bid. Out of these, 13 are in Phase 3. The vast majority of these trials are based in New york City, New York, however, there are a total of 189 locations running these trials."
Share this study with friends
Copy Link
Messenger